Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer (SPRAY III)
This study is currently recruiting participants.
Verified August 2011 by GW Pharmaceuticals Ltd.
Sponsor:
GW Pharmaceuticals Ltd.
Collaborator:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Information provided by (Responsible Party):
GW Pharmaceuticals Ltd.
ClinicalTrials.gov Identifier:
NCT01361607
First received: May 25, 2011
Last updated: April 24, 2013
Last verified: August 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | February 2014 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |